Pharma Foods International Co., Ltd.
PMDSF
$6.24
$0.643211.50%
OTC PK
01/31/2025 | 07/31/2024 | 04/30/2024 | 01/31/2024 | ||
---|---|---|---|---|---|
Revenue | -- | 413.59M | 432.93M | 460.58M | |
Total Other Revenue | -- | -- | -- | -- | |
Total Revenue | -- | 413.59M | 432.93M | 460.58M | |
Cost of Revenue | -- | 89.01M | 88.49M | 92.55M | |
Gross Profit | -- | 324.58M | 344.44M | 368.03M | |
SG&A Expenses | -- | 283.73M | 301.23M | 317.47M | |
Depreciation & Amortization | -- | 663.10K | 677.20K | 693.00K | |
Other Operating Expenses | -- | -- | -- | -- | |
Total Operating Expenses | -- | 379.90M | 396.88M | 417.11M | |
Operating Income | -- | 33.69M | 36.06M | 43.47M | |
Income Before Tax | -- | 33.16M | 35.71M | 43.23M | |
Income Tax Expenses | -- | 12.14M | 8.88M | 8.73M | |
Earnings from Continuing Operations | -- | 21.03 | 26.83 | 34.50 | |
Earnings from Discontinued Operations | -- | -- | -- | -- | |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -7.50K | |
Net Income | -- | 21.03M | 26.83M | 34.49M | |
EBIT | -- | 33.69M | 36.06M | 43.47M | |
EBITDA | -- | 38.04M | 39.94M | 47.43M | |
EPS Basic | -- | 0.74 | 0.94 | 1.20 | |
Normalized Basic EPS | -- | 0.76 | 0.79 | 0.94 | |
EPS Diluted | -- | 0.74 | 0.94 | 1.20 | |
Normalized Diluted EPS | -- | 0.76 | 0.79 | 0.94 | |
Average Basic Shares Outstanding | -- | 113.76M | 114.54M | 115.30M | |
Average Diluted Shares Outstanding | -- | 113.76M | 114.54M | 115.30M | |
Dividend Per Share | -- | 0.16 | 0.15 | 0.15 | |
Payout Ratio | -- | 11.17% | 8.75% | 6.81% |